Allergan's Bid For New Trial Rejected In Zymar Case

Law360, New York (November 4, 2010, 1:27 PM EDT) -- A federal judge has denied Allergan Inc. and other plaintiffs' bid for a new trial concerning the validity of one of the claims of a patent they asserted against Apotex Inc. in a suit over the generic-drug maker's attempt to horn in on the market for pinkeye treatment Zymar.

Judge Sue L. Robinson of the U.S. District Court for the District of Delaware issued a memorandum order Wednesday denying without prejudice a motion filed by Allergan, Senju Pharmaceutical Co. Ltd. and Kyorin Pharmaceutical Co. Ltd. requesting...
To view the full article, register now.